Life Sciences Market IT Spending Projection Market Overview in Italy through 2014

• Publication date: February 2010

About This Report As pharmaceutical and biotechnology industry players increasingly turn to IT to reduce costs and the time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life science industry . This Databook provides a projection and analysis of IT spending in the pharma/biotech markets through to 2014. What's In This Report *Forecast o...

About This Report

As pharmaceutical and biotechnology industry players increasingly turn to IT to reduce costs and the time-to-market of a drug, it is important for technology vendors to understand where growth opportunities exist in the global life science industry . This Databook provides a projection and analysis of IT spending in the pharma/biotech markets through to 2014.

What's In This Report

*Forecast of IT spending within the Italy pharmaceutical and biotechnology industry s by segment, and IT sectors (hardware, software, services)

*Sectors covered are Big Pharma, Mid Pharma, Big Biotech, and Small Pharma & Biotech

Key Market Facts

Although the current economic climate and credit crunch has halted major IT projects for a couple of years, technology investments will continue to grow on a worldwide basis over the next five years, particularly in the biotechnology segment which is becoming a core area of research for future drugs.

Big Pharma will spend the highest amount of money on IT as they are turning to technology solutions to increase efficiencies within the drug lifecycle, reduce costs, and bring the drug to industry faster, but the overall CAGR will be the lowest of the four segments .

Once industry players have the appropriate hardware technologies in place, they will begin to spend a larger portion of their budget on software and services.

Why Should You Buy This Report?

*Understand the opportunity size for technology spending in the life sciences market

*Identify potential areas for spending growth amongst pharmaceutical and biotechnology firms

*Segment the life science market by spending opportunities

IT Services Industry in Italy

TABLE OF CONTENTS
OVERVIEW 1
Catalyst 1
Summary 1
INTRODUCTION 5
Reasons to purchase 5
LIFE SCIENCES IT SPENDING FORECAST IN ITALY 6
Life sciences IT spending overview to 2014 6
Life sciences IT spending by segment to 2014 7
LIFE SCIENCES IT SPENDING BY SECTOR 9
Big Pharma segment IT spending by sector to 2014 9
Mid Pharma segment IT spending by sector to 2014 11
Big Biotech segment IT spending by sector to 2014 13
Small Pharma and Biotech segment IT spending by sector to 2014 15
LIFE SCIENCES IT SPENDING FORECAST IN EUR pe 17
IT spending comparison by country, 2008 17
IT spending by segment to 2014 19
APPENDIX 21
Methodology 21
Further reading 22
How to contact experts in your market 22
Disclaimer 22


Index of Figures
Chart 1: Life sciences market, Italy, IT spending by segment ($m), 2008–14 7
Chart 2: Big Pharma segment, Italy, IT spending by sector ($m), 2008–14 9
Chart 3: Mid Pharma segment, Italy, IT spending by sector ($m), 2008–14 11
Chart 4: Big Biotech segment, Italy, IT spending by sector ($m), 2008–14 13
Chart 5: Small Pharma and Biotech segment, Italy, IT spending by sector ($m), 2008–14 15
Chart 6: Life sciences market, EUR pe, IT sending comparison by country (%), 2008 17
Chart 7: Life sciences market, EUR pe, IT sending comparison by segment ($m), 2008–14 19
Chart 8: Life sciences IT spending, projection methodology flowchart 21


Index of Tables
Data table 1: Life sciences IT spending data specifications 5
Data table 2: Life sciences market, Italy, IT spending ($m), 2008–14 6
Data table 3: Life sciences market, Italy, IT spending by segment ($m), 2008–14 8
Data table 4: Big Pharma segment, Italy, IT spending by sector ($m), 2008–14 10
Data table 5: Mid Pharma segment, Italy, IT spending by sector ($m), 2008–14 12
Data table 6: Big Biotech segment, Italy, IT spending by sector ($m), 2008–14 14
Data table 7: Small Pharma and Biotech segment, Italy, IT spending by sector ($m), 2008–14 16
Data table 8: Life sciences market, EUR pe, IT sending comparison by country ($m and % share), 2008 18
Data table 9: Life sciences market, EUR pe, IT sending comparison by segment ($m), 2008–14 20